Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PFIZER.NSthis companyPfizer Limited	₹3,917.90	29.89×	5.14×	8.57×	20.68×	23.1%	48.0%	33.6%	28.7%	17.2%	14.5%	5.2%	0.02×	-0.03×	89.28×	6.06×	3.5%	4	—	2	B-
ABBOTINDIA.NSAbbott India Limited	₹26,680.00	35.48×	11.53×	7.95×	24.37×	179.8%	36.2%	26.5%	22.4%	32.5%	27.0%	3.0%	0.04×	-0.96×	97.31×	2.55×	1.8%	4	22.4	2	C
AJANTPHARM.NSAjanta Pharma Limited	₹3,344.00	33.18×	7.74×	6.43×	22.46×	64.5%	51.4%	24.3%	19.4%	23.3%	20.5%	0.4%	0.06×	0.1×	82.23×	2.64×	1.0%	5	18.51	4	A
APLLTD.NSAlembic Pharmaceuticals Limited	₹1,017.30	19.32×	2.3×	1.77×	12.9×	3.1%	45.1%	10.9%	9.2%	11.9%	10.4%	2.0%	0.25×	1.11×	8.54×	1.76×	1.7%	4	—	2	B-
CIPLA.NSCipla Limited	₹1,403.80	25.49×	2.87×	3.51×	15.19×	112.4%	42.7%	16.7%	13.8%	11.3%	9.8%	2.6%	0.02×	-0.06×	86.67×	3.44×	1.3%	4	9.92	4	A-
DRREDDY.NSDr. Reddy's Laboratories Limited	₹1,385.00	24.38×	2.77×	3.11×	14.13×	25.1%	52.8%	13.8%	12.8%	11.4%	7.5%	2.9%	0.24×	0.94×	12.42×	1.8×	0.6%	7	5.66	3	B+
Peer median	—	25.49×	2.87×	3.51×	15.19×	64.5%	45.1%	16.7%	13.8%	11.9%	10.4%	2.6%	0.06×	0.1×	82.23×	2.55×	1.3%	4	14.22	3	—